New weekly treatment tested for elderly blood cancer patients

NCT ID NCT02302495

Summary

This study tested a new weekly dosing schedule of a drug called carfilzomib, combined with standard medications, for older adults newly diagnosed with multiple myeloma. The main goals were to find the safest, most effective dose and to see how well the treatment controlled the cancer. It involved 32 participants and was designed to gather information to guide future research.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CH Francilien

    Corbeil-Essonnes, 91106, France

  • CH Louis Pasteur

    Colmar, 68024, France

  • CH Meaux

    Meaux, 77104, France

  • CHRU, Hôpitaux de Brabois

    Vandœuvre-lès-Nancy, 54511, France

  • CHRU, Hôtel Dieu

    Nantes, 44035, France

  • CHU Henri Mondor

    Créteil, 94010, France

  • CHU Nimes CAREMEAU

    Nîmes, 30029, France

  • CHU de Limoges

    Limoges, 87000, France

  • Centre Hospitalier H. Duffaut

    Avignon, 84902, France

  • Centre Hospitalier Lyon Sud -1

    Pierre-Bénite, 69495, France

  • Centre Hospitalier William Morey

    Chalon-sur-Saône, 71100, France

  • Centre Hospitalier de Chambery

    Chambéry, 73011, France

  • Centre Hospitalier de la côte basque

    Bayonne, 64109, France

  • Centre Jean Bernard

    Le Mans, 72000, France

  • Centre de NICE 2/ Hôpital Archet

    Nice, 06202, France

  • Centre hospitalier départemental La Roche sur Yon

    La Roche-sur-Yon, 85025, France

  • Chru Lille

    Lille, 59037, France

  • Groupe hospitalier Pitié Salpétrière

    Paris, 75651, France

  • Hopital J Monod

    Montivilliers, 76290, France

  • Hématologie Clinique, CHU, Hôpital d'Enfants

    Dijon, 21000, France

  • Hématologie Clinique, Hôpital Robert Debré, CHU Reims

    Reims, 51092, France

  • Hématologie, IUCT oncopole

    Toulouse, 31059, France

  • Hématologie, Institut Paoli Calmette

    Marseille, 13273, France

  • Hôpital E Muller

    Mulhouse, 68100, France

  • Hôpital Haut-Leveque

    Pessac, 33604, France

  • Hôpital Jean Minjoz

    Besançon, 25030, France

  • Hôpital Notre Dame de Bon Secours

    Metz, 57038, France

  • Hôpital St Antoine

    Paris, 75571, France

  • Hôpital St Antoine Béclére

    Clamart, 92140, France

  • Hôpital St Vincent de Paul - GH-ICL

    Lille, 59020, France

  • Institut Bergonie

    Bordeaux, 33076, France

  • Polyclinique Bordeaux Nord Aquitaine

    Bordeaux, 33300, France

  • Unité de Recherche Clinique - CH Perigueux

    Périgueux, 24019, France

Conditions

Explore the condition pages connected to this study.